MX9709299A - Uso de las l-carnitinas de alcanoilo inferior para producir un medicamento apropiado para el tratamiento terapeutico de retinopatias. - Google Patents

Uso de las l-carnitinas de alcanoilo inferior para producir un medicamento apropiado para el tratamiento terapeutico de retinopatias.

Info

Publication number
MX9709299A
MX9709299A MX9709299A MX9709299A MX9709299A MX 9709299 A MX9709299 A MX 9709299A MX 9709299 A MX9709299 A MX 9709299A MX 9709299 A MX9709299 A MX 9709299A MX 9709299 A MX9709299 A MX 9709299A
Authority
MX
Mexico
Prior art keywords
carnitines
retinopathies
produce
therapeutic treatment
lower alkanoyl
Prior art date
Application number
MX9709299A
Other languages
English (en)
Other versions
MXPA97009299A (es
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti, S P A filed Critical Sigma Tau Ind Farmaceuti
Publication of MX9709299A publication Critical patent/MX9709299A/es
Publication of MXPA97009299A publication Critical patent/MXPA97009299A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se describe el uso de las L-carnitinas de alcanoilo inferior (por ejemplo acetil-L-carnitina) y las sales farmacéuticamente aceptables de las mismas, para producir un medicamento adecuado para el tratamiento terapéutico de retinopatías, por ejemplo la maculopatía relacionada a la edad (ARM) y la maculopatía no relacionada a la edad (nARM).
MXPA/A/1997/009299A 1996-12-03 1997-12-01 Uso de las l-carnitinas de alcanoilo inferior para producir un medicamento apropiado para eltratamiento terapeutico de retinopatias MXPA97009299A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96RM000827A IT1288399B1 (it) 1996-12-03 1996-12-03 Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
RMRM96A000827 1996-12-03

Publications (2)

Publication Number Publication Date
MX9709299A true MX9709299A (es) 1998-10-31
MXPA97009299A MXPA97009299A (es) 1999-01-11

Family

ID=

Also Published As

Publication number Publication date
US5883127A (en) 1999-03-16
IT1288399B1 (it) 1998-09-22
KR19980063712A (ko) 1998-10-07
ZA9710812B (en) 1998-07-01
CA2223349A1 (en) 1998-06-03
EP0848952A1 (en) 1998-06-24
JPH10167963A (ja) 1998-06-23
ITRM960827A1 (it) 1998-06-03
ITRM960827A0 (it) 1996-12-03

Similar Documents

Publication Publication Date Title
EP0787489A3 (es)
EP0299602A3 (en) Use of indolone derivatives for the treatment of parkinsons disease
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
UA41446C2 (uk) Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі
MX9701538A (es) Sales de un derivado del indol contra la migraña.
WO1997005862A3 (en) Use of basic amino acids and derivatives for lowering ceramide levels
PL342099A1 (en) Therapeutic agents
EP0376899A3 (en) Use of L-carnitine derivatives for the manufacture of a medicament for the therapeutical treatment of peripheral neuropathies
ZA941464B (en) Use of pregnane derivative
ZA922910B (en) Heterocylic pharmaceutical compounds preparation and use
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
CA2256514A1 (en) Veterinary use of a pleuromutilin derivative
ZA9710812B (en) Use of lower alkanoyl l-carnitines to produce a medicament suitable for the therapeutic treatment of retinopathies
TW362972B (en) Use of lower alkanoyl L-carnitines to produce a medicament suitable for the therapeutic treatment of retinopathies
AU670491C (en) Pharmaceutical for the treatment of skin disorders
GR1002576B (el) Φαρμακευτικες συνθεσεις και μια μεθοδος παρασκευης τους.
GR3034062T3 (en) Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease
AU1494395A (en) The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
IL117465A (en) Use of certain cystine derivatives for the preparation of a medicament for the treatment of restenosis
HU9502320D0 (en) Use of inhibitors of ornitine aminotransferase for the manufacture of a medicament for the treatment of alzheimer's disease and process to prepare (2s,5s)-5-fluoromethylornithine
GR3037039T3 (en) Use of trimetazidine for the preparation of medicaments for the treatment of troubles due to the therapeutical use of immunosuppressants.
GR3031908T3 (en) Novel 17-hydroxyiminoalkyl and 17-hydroxyiminomethylalkenyl cyclopentaneperhydrophenanthrene derivatives active on the cardiovascular system, a process for their preparation and pharmaceutical compositions containing same
FI933872A0 (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,3,4-bensotriazepin-5(4h)-on-derivat
MX9709438A (es) Ester-amidas de acido 3-hidroxi-piridina-2-carboxilico, su preparacion y su utilizacion como medicamentos.
AU9166598A (en) Use of sulphonanilide derivatives to obtain a medicine for treating retrograde ejaculation or aspermia

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees